Wehinger E - Search Results

1

Pharmacokinetics of nisoldipine. III. Biotransformation of nisoldipine in rat, dog, monkey, and man.

Scherling D, Karl W, Ahr G, Ahr HJ, Wehinger E. Scherling D, et al. Among authors: wehinger e. Arzneimittelforschung. 1988 Aug;38(8):1105-10. Arzneimittelforschung. 1988. PMID: 2973788

2

Nimodipine: synthesis and metabolic pathway.

Meyer H, Wehinger E, Bossert F, Scherling D. Meyer H, et al. Among authors: wehinger e. Arzneimittelforschung. 1983;33(1):106-12. doi: 10.1002/chin.198320206. Arzneimittelforschung. 1983. PMID: 6681961

3

Pharmacology of a new calcium antagonistic compound, isobutyl methyl 1,4-dihydro-2,6-dimethyl-4(2-nitrophenyl)-3,5-pyridinedicarboxylate (Nisoldipine, Bay k 5552).

Kazda S, Garthoff B, Meyer H, Schlossmann K, Stoepel K, Towart R, Vater W, Wehinger E. Kazda S, et al. Among authors: wehinger e. Arzneimittelforschung. 1980;30(12):2144-62. Arzneimittelforschung. 1980. PMID: 7194077 No abstract available.

4

[Synthesis and comparative pharmacological studies of 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylates with non-identical ester functions (author's transl)].

Meyer H, Bossert F, Wehinger E, Stoepel K, Vater W. Meyer H, et al. Among authors: wehinger e. Arzneimittelforschung. 1981;31(3):407-9. Arzneimittelforschung. 1981. PMID: 7194663 German.

5

[2-aminodihydropyridines / Structure and antihypertensive activity (author's transl)].

Meyer H, Wehinger E, Bossert F, Stoepel K, Vater W. Meyer H, et al. Among authors: wehinger e. Arzneimittelforschung. 1981;31(8):1173-7. Arzneimittelforschung. 1981. PMID: 7197524 German.

6

The effects of nimodipine, its optical isomers and metabolites on isolated vascular smooth muscle.

Towart R, Wehinger E, Meyer H, Kazda S. Towart R, et al. Among authors: wehinger e. Arzneimittelforschung. 1982;32(4):338-46. Arzneimittelforschung. 1982. PMID: 7201802 No abstract available.

7

Chemistry of calcium antagonists.

Meyer H, Bossert F, Wehinger E, Towart R, Bellemann P. Meyer H, et al. Among authors: wehinger e. Hypertension. 1983 Jul-Aug;5(4 Pt 2):II2-7. doi: 10.1161/01.hyp.5.4_pt_2.ii2. Hypertension. 1983. PMID: 6345372 Review. No abstract available.

8

Effects of unsymmetrical ester substituted 1,4-dihydropyridine derivatives and their optical isomers on contraction of smooth muscle.

Towart R, Wehinger E, Meyer H. Towart R, et al. Among authors: wehinger e. Naunyn Schmiedebergs Arch Pharmacol. 1981 Sep;317(2):183-5. doi: 10.1007/BF00500079. Naunyn Schmiedebergs Arch Pharmacol. 1981. PMID: 7300922

9

Photoaffinity labelling of a 33-35,000 dalton protein in cardiac, skeletal and smooth muscle membranes using a new 125I-labelled 1,4-dihydropyridine calcium channel antagonist.

Sarmiento JG, Epstein PM, Rowe WA, Chester DW, Smilowitz H, Wehinger E, Janis RA. Sarmiento JG, et al. Among authors: wehinger e. Life Sci. 1986 Dec 22;39(25):2401-9. doi: 10.1016/0024-3205(86)90481-9. Life Sci. 1986. PMID: 2432371

10

Erratum to: Optogenetics in Plants: Red/Far-Red Light Control of Gene Expression.

Ochoa-Fernandez R, Samodelov SL, Brandl SM, Wehinger E, Müller K, Weber W, Zurbriggen MD. Ochoa-Fernandez R, et al. Among authors: wehinger e. Methods Mol Biol. 2016;1408:E1. doi: 10.1007/978-1-4939-3512-3_28. Methods Mol Biol. 2016. PMID: 27314667 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16 results

Search Page

Filters